OPUS Cal D 400
Natural health product licensed in Canada
- Licence holder
- Opus Pharma
- NPN or DIN-HM
- 80020974
- Status
- Active licence
- Licence date
- 28 July 2010
- Revision date
- 20 February 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Calcium: up to 1,000 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Carbonate de calcium | 500 mg | 1,000,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 400 UI | 10 µg | 20 µg |
| Vitamine D Source : Vitamine D3 Potency : 400 UI | 10 µg | 20 µg |
Non-medicinal ingredients
Poly(éthylène glycol), Laque d'aluminium jaune FD&C No. 5, Croscarmellose de sodium, Cellulose microcristalline, Poly(alcool vinylique), ascorbate de sodium, Dioxyde de silicium colloïdal, Talc, dl-alpha tocophérol, Dioxyde de titane, Maltodextrine, Triglycérides à chaîne moyenne, Laque d'aluminium bleu FD&C No 2, Amidon de maïs modifié, Gomme arabique (acacia), Stéarate de magnésium, Laque d'aluminium jaune FD&C No. 6, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Le calcium et la vitamine D aident au développement et au maintien des os et des dents. La consommation de calcium, lorsqu`elle s`accompagne d`un apport suffisant en vitamine D, d`une alimentation saine et de la pratique régulière d`une activité physique, peut réduire le risque d`ostéoporose. La vitamine D aide à l`absorption et à l`utilisation du calcium et du phosphore.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80020974
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.